No product was returned and because a serial number was not provided, a manufacturing review could not be performed.However, based on the customer report, this event was determined to be related to user error.The facility will be switching from aminosyn ii 10% to travasol 10% and will set up appropriate curve data for travasol.The abacus user guide directs users to thoroughly review all data because serious harm or death may occur if an adequate review isn't completed.The abacus software changes an order to complete only after an authorized user completely finishes and approves an order.A thorough review of all data on each tab in the order entry process will minimize the risk of medication error.The abacus user guide also warns that users should keep in mind the potential of precipitate formation during parenteral nutrition admixture, even when using appropriate curve data, and that decisions regarding drug therapy must be based on professional judgment.This event is logged under complaint file (b)(4).
|
The customer reported that when entering orders containing aminosyn ii 10% into abacus, they were using clinamix 10% curve data since they did not have curve data for aminosyn ii 10%.Curve data represents a comparison of a given tpn order to calcium phosphate solubility, as specified by drug/solution templates provided by manufacturers.This data is presented in abacus as a graph showing the likelihood of precipitation formation in the order.In this situation, using inaccurate curve data could result in the formation of precipitate in the compounded product.The compounded product was released for patient use.However, there was no report of patient injury or adverse event in relation to this event.No additional information is available.
|